Literature DB >> 9236833

Lymph node involvement by splenic marginal zone lymphoma: morphological and immunohistochemical features.

M Mollejo1, E Lloret, J Menárguez, M A Piris, P G Isaacson.   

Abstract

Splenic marginal zone lymphoma (SMZL) has recently been proposed as a distinctive type of low-grade B-cell lymphoma. Although there is general agreement that this entity exists, its precise definition is blurred by uncertainty in differential diagnosis from other low-grade B-cell lymphomas. There is even more uncertainty as to the histology of splenic hilar and peripheral lymph nodes involved by SMZL. We therefore reviewed the histological and immunohistochemical features of 19 of these lymph nodes (14 hilar and five peripheral) from 14 cases of classical SMZL and compared them with the features of lymph nodes involved by other B-cell lymphomas. The morphology and immunohistology of the lymph nodes resemble those found in the white pulp of the spleen, showing a distinctive pattern, different from that which is observed in other B-cell lymphomas. In these cases, the overall architecture of the lymph nodes is effaced and replaced by a nodular infiltrate, although the sinuses are preserved in most hilar lymph nodes. Some of the nodules contain a central reactive follicular center, around which there is a broad zone of small lymphocytes. In other cases, the central area is partially infiltrated or, more commonly, totally replaced by these small lymphocytes, which in the periphery of the nodules showed a pale, slightly larger cytoplasm. Scattered nucleolated blasts are present, largely confined to the periphery of the nodules. The tumoral cells express immunoglobulin (Ig)D, IgM, and Ig light chain restriction and show a low proliferation fraction. These findings confirm that SMZL is a real entity, and not merely a morphological pattern of splenic infiltration by different types of low-grade B-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236833     DOI: 10.1097/00000478-199707000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.

Authors:  M Sol Mateo; M Mollejo; R Villuendas; P Algara; M Sánchez-Beato; B Martinez-Delgado; P Martínez; M A Piris
Journal:  Mol Pathol       Date:  1998-10

2.  Splenic marginal zone lymphomas appear to originate from different B cell types.

Authors:  David W Bahler; J Ander Pindzola; Steven H Swerdlow
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

3.  7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.

Authors:  M Mateo; M Mollejo; R Villuendas; P Algara; M Sanchez-Beato; P Martínez; M A Piris
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

4.  Unexpected dissemination patterns in lymphoma progression revealed by serial imaging within a murine lymph node.

Authors:  Ken Ito; Bryan Ronain Smith; Natesh Parashurama; Joon-Kee Yoon; Si Yeol Song; Cornelius Miething; Parag Mallick; Scott Lowe; Sanjiv Sam Gambhir
Journal:  Cancer Res       Date:  2012-10-02       Impact factor: 12.701

5.  [Lymphomas of the spleen].

Authors:  A Marx; H K Müller-Hermelink; M Hartmann; E Geissinger; A Zettl; P Adam; T Rüdiger
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

6.  [Splenic marginal zone B cell lymphomas].

Authors:  M M Ott; H K Müller-Hermelink
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

7.  Paraneoplastic Syndrome in Splenic Marginal Zone Lymphoma: A Rare Phenomenon of Paraplegia as an Atypical Presenting Manifestation.

Authors:  Jessica Schering; Vijayalakshmi Donthireddy
Journal:  Case Rep Hematol       Date:  2016-05-11

8.  A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade.

Authors:  Peter G Miller; Adam S Sperling; Christopher J Gibson; Olga Pozdnyakova; Waihay J Wong; Michael P Manos; Elizabeth I Buchbinder; F Stephen Hodi; Benjamin L Ebert; Matthew S Davids
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

Review 9.  CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.

Authors:  John J Schmieg; Jeannie M Muir; Nadine S Aguilera; Aaron Auerbach
Journal:  Curr Oncol       Date:  2021-12-04       Impact factor: 3.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.